US 9,801,918 B2Granted

Methods of treatment using extracts of Anisomeles heyneana

AssigneeCouncil of Scientific and Industrial Research

InventorsSwati Pramod Joshi, Roshan Rajan Kulkarni, Ketaki Dilip Shurpali, Sampa Sarkar, Dhiman Sarkar

Life of this patent

Estimating the term…

Abstract

The present invention describes the use of pharmaceutical compositions including compounds of formula 2 (below) for treatment of infections related to M. tuberculosis and for anti-proliferative activity. Also, the present invention discloses a process of extraction of compounds of formula 2 from the extract of aerial parts of Anisomeles heyneana:

Claims3

Dependent claims

A method of inhibiting cell proliferation in human Thp-1 cell line by administering to the cell a composition of a compound extracted from Anisomeles heyneana of formula:

Dependencies are inferred from the claim text.

Facts

Application: 15/168,643Filed 31 May 2016 · continuation
Priority: IN 2222/DEL/20115 Aug 2011
Published: US 2016/0271196 A122 Sep 2016
Granted: 31 Oct 2017
Term ends: Not estimatedThe source records don’t support an estimate.

Classification16 codes

A61K 36/53
Magnoliopsida: lamiaceae or Labiatae , e.g. thyme, rosemary or lavender
A61K 31/191
Carboxylic acids, e.g. valproic acid: having two or more hydroxy groups, e.g. gluconic acid
A61K 31/365
Having oxygen as the only ring hetero atom, e.g. fungichromin: lactones
A61P 31/06
Antibacterial agents: for tuberculosis

Family

PCT/IB2012/001508Parent of this continuation · filed 6 Aug 2012
US 2016/0271196 A1Pre-grant publication · published 22 Sep 2016
Application14/237,314Parent of this continuation
US 2015/0051277 A1Published application
US 9,801,918 B2This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

patentgrep

Loading patent…

patentgrepSearch patents

Back to results